Ohio Public Employees Retirement System (OPERS)’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,388
Closed -$69.3K 2309
2025
Q4
$69.3K Hold
13,388
﹤0.01% 1870
2025
Q3
$69.9K Buy
13,388
+6,888
+106% +$35.9K ﹤0.01% 1851
2025
Q2
$24.9K Buy
+6,500
New +$16.8K ﹤0.01% 2129
2024
Q4
Sell
-3,500
Closed -$18.9K 2352
2024
Q3
$18.9K Buy
+3,500
New +$16.7K ﹤0.01% 2054
2020
Q3
Sell
-11,647
Closed -$49K 1912
2020
Q2
$49K Buy
+11,647
New +$42.5K ﹤0.01% 1708

Other funds holding ALDX

Ohio Public Employees Retirement System (OPERS)'s ALDX Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 13,388 shares — an estimated $69.3K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in ALDX in Q2 2020 and held it in 5 quarters. The position peaked at $69.9K in Q3 2025. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 13,388 Aldeyra Therapeutics shares in Q1 2026, an estimated $69.3K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 5 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Aldeyra Therapeutics position peaked at $69.9K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.